| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | This Is What Whales Are Betting On Insmed | 1 | Benzinga.com | ||
| Fr | Earnings call: Insmed reports positive results and growth in Q1 2024 | 1 | Investing.com | ||
| Do | Insmed Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| Do | Insmed reports mixed Q1 results; reaffirms FY24 outlook | 1 | Seeking Alpha | ||
| Do | INSMED Inc - 8-K, Current Report | 1 | SEC Filings | ||
| Do | INSMED Inc - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Do | Insmed Incorporated: Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update | 47 | PR Newswire | - ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $75.5 Million for the First Quarter of 2024, Reflecting 16% Annual Growth Over the First Quarter of 2023-
-Company Reports Positive... ► Artikel lesen | |
| 03.05. | Insmed Incorporated: Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 37 | PR Newswire | BRIDGEWATER, N.J., May 3, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases... ► Artikel lesen | |
| 10.04. | What Makes Insmed (INSM) a Lucrative Investment? | 4 | Insider Monkey | ||
| 05.04. | Insmed Incorporated: Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 85 | PR Newswire | BRIDGEWATER, N.J., April 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases... ► Artikel lesen | |
| 11.03. | INSMED Inc - 8-K, Current Report | 2 | SEC Filings | ||
| 05.03. | Insmed Incorporated: Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 54 | PR Newswire | BRIDGEWATER, N.J., March 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases... ► Artikel lesen | |
| 05.03. | Jane Seymour backs Insmed's push to tackle gender and age biases | 1 | FiercePharma | ||
| 23.02. | Earnings call: Insmed reports strong position with $780M year-end cash | 2 | Investing.com | ||
| 23.02. | Insmed Incorporated (INSM) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 22.02. | INSMED Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 22.02. | Insmed GAAP EPS of -$1.28 misses by $0.13, revenue of $83.69M beats by $1.08M | 3 | Seeking Alpha | ||
| 22.02. | Insmed Incorporated: Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update | 227 | PR Newswire | -Topline Data from the Phase 3 ASPEN Trial of Brensocatib in Adult Patients with Bronchiectasis Remain on Track to Read Out in the Latter Part of Second-Quarter 2024-
-Enrollment in the Phase 2 Study... ► Artikel lesen | |
| 22.02. | INSMED Inc - 10-K, Annual Report | 3 | SEC Filings | ||
| 21.02. | Insmed Q4 2023 Earnings Preview | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 233 |
| BAYER | 192 |
| TUI | 184 |
| NEL | 170 |
| SIEMENS ENERGY | 167 |
| NOVAVAX | 143 |
| RHEINMETALL | 143 |
| MERCEDES-BENZ | 134 |
| PLUG POWER | 131 |
| PALANTIR TECHNOLOGIES | 129 |
| NVIDIA | 119 |
| RWE | 118 |
| TESLA | 110 |
| BYD | 98 |
| ALLIANZ | 95 |
| DEUTSCHE BANK | 95 |
| BASF | 88 |
| COMMERZBANK | 78 |
| DEUTSCHE LUFTHANSA | 77 |
| VOLKSWAGEN | 73 |
| INFINEON | 72 |
| JINKOSOLAR | 72 |
| HELLOFRESH | 66 |
| PAYPAL | 66 |
| NORDEX | 65 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
